Back

Impact of stepwise dual antiplatelet therapy de-escalation in patients with high bleeding risk undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trial

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Chao Gao

First Affiliated Hospital of University of Science and Technology of China, Hefei (China)

7 More presentations in this session

Presentation thumbnail
Effect of beta-blockers on cardiovascular hospitalisation after myocardial infarction: A substudy of the BETAMI-DANBLOCK trial.
Doctor H. Caglar (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Troponin-stratified outcomes of extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome: insights from the OPT-BIRISK randomized trial
Professor M. Qiu (Shenyang, CN)
Abstract Slides
Presentation thumbnail
Coordinated post-myocardial infarction care versus the PCSK9 modulator drug program: a comparative outcomes study
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Long-term effect of beta-blockers after myocardial infarction with preserved left ventricular ejection fraction in a per protocol analysis of the REDUCE-AMI trial
Professor T. Jernberg (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Long-term clinical outcomes of beta-blocker therapy in elderly patients with preserved left ventricular function after percutaneous coronary intervention for acute myocardial infarction
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides

Access the full session

Session thumbnail
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk
27 August 2023
thumbnail
Congress Presentation
Prasugrel-based de-escalation vs. conventional therapy after percutaneous coronary intervention in ACS patients according to the renal function
3 December 2022
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation or abbreviation: if I had to choose one of them
30 August 2025
thumbnail
Webinar
The EAPCI Journal Club: T-PASS Randomised Trial
14 November 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources